Outlook Therapeutics Inc.

NASDAQ: OTLK · Real-Time Price · USD
2.33
-0.10 (-4.12%)
At close: Aug 15, 2025, 3:08 PM

Outlook Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
14.93M 23.39M 17.4M 14.48M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
693.19K 793.93K 804.93K 853.66K
Other Long-Term Assets
439.28K 501.3K 132.01K 174.59K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
12.49M 7.59M n/a 324.00
Total Current Assets
27.42M 30.98M 27.52M 21.51M
Property-Plant & Equipment
274.64K 26.17K 70.36K 275.05K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.41M 1.32M 1.01M 1.3M
Total Assets
28.82M 32.3M 28.53M 22.81M
Account Payables
7.97M 6.57M 3.49M 2.2M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
29.44M 35.55M 10.92M 904.2K
Other Current Liabilities
n/a 1.83M 1.45M 2.83M
Total Current Liabilities
42.55M 46.73M 19.73M 6.75M
Long-Term Debt
n/a n/a n/a 10.89M
Other Long-Term Liabilities
59.1M 6.22K 57.14K 522.92K
Total Long-Term Liabilities
59.35M 6.22K 61.41K 11.45M
Total Liabilities
101.9M 46.74M 19.79M 18.2M
Total Debt
29.74M 35.56M 10.96M 11.9M
Common Stock
239.06K 2.6M 2.27M 1.76M
Retained Earnings
-543.28M -467.92M -408.94M -342.88M
Comprehensive Income
n/a -32,300.6B 417.67M -22,811.5B
Shareholders Equity
-73.08M -14.44M 8.74M 4.61M
Total Investments
693.19K 793.93K 804.93K 853.66K